Stock Market Today, Aug. 19: Moderna Skyrockets 177% on Positive Phase 3 Melanoma Data
Phase 3positivePositive
AI Analysis
Summary
Moderna announced positive Phase 3 data for a melanoma treatment, causing the stock to surge approximately 177%. The data readout represents a significant clinical milestone for the company's oncology program.
Clinical Trial Data
Phase
3
Primary Endpoint
Met
Importance:8/10
Sentiment:
0.85
Phase 3melanomapositive datastock surge
Related Companies
Read the original article
Published by yahoo_finance on August 19, 2026 9:21 PM